TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06420323 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06158399 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05216549 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06541093 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06442618 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06653088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04568616 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06110507 — Safety Biomarker (SAF): DRD2
Study NCT05613738 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05793853 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06101784 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05465317 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05817058 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study NCT05817058 — Predictive Biomarker (PRD): IL3RA mRNA
Genes: IL3RA; IL3R
Study NCT05125341 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05814536 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05574387 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05574387 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05161299 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04954599 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04954599 — Predictive Biomarker (PRD): BRCA2
Genes: FAD; FAD1; BRCC2; XRCC11
Study NCT05930834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT06404060 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06111417 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06111417 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06410274 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05801107 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06463808 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06141226 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT05180227 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05180227 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05634954 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05323994 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06655311 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06593119 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05890690 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06591325 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06591325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06591325 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06595563 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05961410 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06702384 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT06703593 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05304195 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT06586203 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study NCT06586203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06592625 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06592625 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05378815 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04852796 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05691608 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06293118 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05546723 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT06327464 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05769322 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04223622 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06195072 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04151225 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study NCT06475456 — Predictive Biomarker (PRD): SCAI mRNA
Genes: SCAI; C9orf126
Study NCT06475456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05874479 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06466850 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05839119 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04535050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05410041 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01419912 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05213793 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT05444595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05048927 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05247671 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT05247671 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study NCT06116994 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06163443 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study NCT06163443 — Predictive Biomarker (PRD): MTRR mRNA
Genes: MTRR
Study NCT06218030 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06218030 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05165173 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05165173 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06563440 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06030648 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05517005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06622694 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06623110 — Predictive Biomarker (PRD): RP2 mRNA
Genes: RP2
Study NCT05625308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05625308 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06402266 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05176275 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06420427 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06210321 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04670588 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06319014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05751187 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05121688 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06568445 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04818060 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT04965818 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04916509 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04916509 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04916509 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04916509 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05661643 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT05488587 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06076720 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06631482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06629233 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05356897 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05356897 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05356897 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05356897 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06375161 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05588869 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06025032 — Predictive Biomarker (PRD): OTOF mRNA
Genes: OTOF; FER1L2
Study NCT06564155 — Predictive Biomarker (PRD): IL33 mRNA
Genes: IL33; C9orf26; IL1F11; NFHEV
Study NCT04383210 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT05341583 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06146920 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05838846 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05999357 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05997290 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05485571 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT05485571 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04854187 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06061926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05146882 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05087290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05349279 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05844579 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04760288 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04911803 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06654362 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06655519 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06655519 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06601595 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06604117 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06594874 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00000822 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05178238 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06594861 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT05413850 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05161546 — Predictive Biomarker (PRD): KCNH2 mRNA
Genes: KCNH2; ERG; ERG1; HERG
Study NCT05156385 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06395610 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06587425 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05514886 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05458713 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06314074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04335292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04335292 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05222373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00802061 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06576752 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06061848 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05847569 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05720026 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05720026 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04784182 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT04784182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04962022 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05565001 — Predictive Biomarker (PRD): CSAD mRNA
Genes: CSAD; CSD
Study NCT06130124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06649812 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT06649812 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT06649812 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05718323 — Predictive Biomarker (PRD): SLFN11 mRNA
Genes: SLFN11
Study NCT05703815 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05703815 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06277466 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05403346 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05064852 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05326984 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT05326984 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT06540924 — Predictive Biomarker (PRD): LBX1 mRNA
Genes: LBX1; LBX1H
Study NCT06540924 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT06540924 — Predictive Biomarker (PRD): CHD7 mRNA
Genes: CHD7; KIAA1416
Study NCT05711004 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05833763 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05754502 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06431152 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04513223 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04695795 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04695795 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05265091 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05132907 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05530265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04951817 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06700876 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05493917 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06026917 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT06703008 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04639310 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT05798923 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00002369 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06048718 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06048718 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04938583 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04353180 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT04353180 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04353180 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study NCT04353180 — Predictive Biomarker (PRD): MAVS mRNA
Genes: MAVS; IPS1; KIAA1271; VISA
Study NCT04353180 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04353180 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04353180 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05489991 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05855707 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05394064 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT06029348 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06035016 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06035016 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06035016 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT06354972 — Predictive Biomarker (PRD): ASPRV1 mRNA
Genes: ASPRV1; SASP
Study NCT06189521 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05098067 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT06318949 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03473288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04869826 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05557487 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05557487 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05557487 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06105008 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06105008 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06105008 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06105008 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04432090 — Predictive Biomarker (PRD): GPR119 mRNA
Genes: GPR119
Study NCT05747456 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05910996 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06643416 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06643416 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06643416 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05790122 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06183658 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06183658 — Predictive Biomarker (PRD): SGCA mRNA
Genes: SGCA; ADL; DAG2
Study NCT05494723 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05995028 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05640193 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06653361 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05489523 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06655662 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06588946 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06590246 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06586372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06587074 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05304351 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06604390 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06604390 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06604390 — Safety Biomarker (SAF): BDNF
Study NCT06604390 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04949490 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00016783 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04948554 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04753073 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04806464 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT05433181 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05433181 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06300476 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT05133388 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT04484077 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06213857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06213857 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06567483 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06560996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05998421 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT05643118 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06618521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06618521 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06618521 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04557891 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06380491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04316442 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05596032 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05809024 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05809024 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05809024 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05210998 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05621434 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL